209 related articles for article (PubMed ID: 6085391)
1. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391
[TBL] [Abstract][Full Text] [Related]
2. Verapamil-induced vasodilation is enhanced in essential hypertension.
Hulthén UL; Bolli P; Amann FW; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S313-8. PubMed ID: 6184560
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
Franz IW; Wiewel D
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
[TBL] [Abstract][Full Text] [Related]
4. Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension.
Bolli P; Erne P; Ji BH; Block LH; Kiowski W; Bühler FR
J Hypertens Suppl; 1984 Dec; 2(3):S115-8. PubMed ID: 6100732
[TBL] [Abstract][Full Text] [Related]
5. Calcium influx mediated vasoconstriction: studies in patients with mild and moderate essential hypertension.
Hulthén UL; Bolli P; Bühler FR
J Hypertens Suppl; 1983 Dec; 1(2):105-8. PubMed ID: 6599487
[TBL] [Abstract][Full Text] [Related]
6. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.
Erne P; Bolli P; Bürgisser E; Bühler FR
N Engl J Med; 1984 Apr; 310(17):1084-8. PubMed ID: 6143260
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of nitrendipine monotherapy in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
[TBL] [Abstract][Full Text] [Related]
8. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
Pedrinelli R; Tarazi RC
J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491
[TBL] [Abstract][Full Text] [Related]
9. Ouabain-induced elevation in forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade, and release and removal of noradrenaline.
Schulte KL; van Gemmeren D; Thiede HM; Meyer-Sabellek W; Gotzen R; Distler A
J Hypertens Suppl; 1987 Dec; 5(5):S215-8. PubMed ID: 2895170
[TBL] [Abstract][Full Text] [Related]
10. [Antihypertensive effect of nitrendipine, nifedipine and acebutolol and their combination on resting and exercise blood pressure in hypertensive patients].
Franz IW; Wiewel D
Z Kardiol; 1985 Feb; 74(2):111-6. PubMed ID: 3158125
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment.
Paulis L; Lísková S; Pintérová M; Dobesová Z; Kunes J; Zicha J
Acta Physiol (Oxf); 2007 Dec; 191(4):255-66. PubMed ID: 17680837
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
[TBL] [Abstract][Full Text] [Related]
13. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
Kazda S; Garthoff B; Knorr A
Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
[TBL] [Abstract][Full Text] [Related]
14. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison of systemic vs. local effects.
Pedrinelli R; Tarazi RC
J Pharmacol Exp Ther; 1985 Jun; 233(3):643-9. PubMed ID: 2861275
[TBL] [Abstract][Full Text] [Related]
15. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension.
Hulthén UL; Bolli P; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S75-81. PubMed ID: 6204162
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of calcium antagonists in hypertension.
Kiowski W; Bolli P; Erne P; Hulthén UL; Bühler FR
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
[TBL] [Abstract][Full Text] [Related]
17. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
[TBL] [Abstract][Full Text] [Related]
18. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
Kiowski W; Linder L; Erne P
J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
[TBL] [Abstract][Full Text] [Related]
20. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
